Pharma15 Live! sat down Valerie Bowling, drug development industry researcher and founder of DPharm, during the conference to discuss this year’s presentations, and the very popular DPharm Idol competition:
Topics: Pharma15, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences
What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.
Topics: Pharma15, Patient Experience, clinical research, clinical trials, patient data, Disruptive Innovation, Conferences, Most Viewed
We are very excited to announce that our next Pharma15 Live! event will be held in conjunction with the 8th annual DPharm: Disruptive Innovations conference in Boston, September 25-26.
Topics: Conferences, Disruptive Innovation
We sat down with drug development industry researcher Valerie Bowling, a veteran conference director who covers the clinical trials market, to discuss her views on R&D trends and challenges and why she launched DPharm, a disruptive thinking conference for clinical trials (held this year in Boston, September 25-26).
Topics: Conferences, Disruptive Innovation, clinical research
Experts across the healthcare industry agree that patients should be able to easily access their medical data. While this sentiment is shared among key industry stakeholders, the ideas of “consumer centricity”, and how researchers specifically stand to benefit from delivering patient data, are popular talking points among experts in our industry.
Topics: patient data, clinical research, clinical trials, Pharma15
When it comes to digital health, do you believe that we are past the era of hype and into the era of adoption? Is there a degree of skepticism that still inhibits the wider adoption of digital health solutions in clinical research and healthcare?
Topics: digital health, Pharma15, Digital Platforms, Patient Recruitment
The idea of “digital patient engagement” continues to be one of the hottest topics in the healthcare industry, and according to BBK Worldwide director of innovation Erica Mercado, everyone defines this term in different ways. For instance, apps, wearables, and digital outreach and messaging are all tactics that can be effectively deployed to keep patients engaged. But for Erica, truly effective digital patient engagement amounts to more than the sum of its parts.
Topics: Pharma15, Patient Experience, digital health, Patient Engagement, Vlog
Even when we consider the strict regulations inherent to the healthcare industry, we are still years behind where we should be with regard to the adoption of mobile health technologies. Just look to other highly regulated sectors, like banking and finance; we see that adoption of mobile technology in these industries is much more established.
Topics: Pharma15, mHealth, digital health
There is no doubt that Amazon’s recent acquisition of PillPack – the independent pharmacy and medication distribution system – has major implications not only for the clinical research industry, but the healthcare industry at-large. We asked BBK Worldwide president Matt Kibby to weigh in on Amazon’s foray into the pharmaceutical space.
For digital health to be more widely implemented across the healthcare industry, smaller biopharma companies must be the first to demonstrate its efficacy. In this way, they must deliver specific real-world cases to prove to bigger pharma companies that digital health solutions are viable for the clinical R&D industry.
Topics: digital health, mHealth, clinical research, clinical trials